PACAP attenuates 5-HT, histamine, and ATP-evoked Ca2+ transients in astrocytes

NeuroReport

Volumn 20, Issue 10, 2009, Pages 957-962

  Hansson, Elisabeth ^a   Westerlund, Anna ^a   Björklund, Ulrika ^a   Rönnbäck, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5 HT; Astrocytes; ATP; Calcium; Histamine; Inflammation; PACAP

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; DUAL SPECIFICITY PHOSPHATASE 2; HISTAMINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; SEROTONIN; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; ATTENUATION; BRAIN CELL; CALCIUM TRANSPORT; COCULTURE; CONCENTRATION RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; MICROVASCULATURE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CALCIUM SIGNALING; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENCEPHALITIS; ENDOTHELIAL CELLS; GLIOSIS; HISTAMINE; MICROCIRCULATION; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 67651108694     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32832ca201     Document Type: Article

References (27)

1. Masmoudi-Kouki O, Gandolfo P, Castel H, Leprince J, Fournier A, Dejda A, et al. Role of PACAP and VIP in astroglial functions. Peptides 2007; 28:1753-1760. (Pubitemid 47361428)
2. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclise-activating polypeptide. Pharmacol Rev 1998; 50:265-270.
3. Grimaldi M, Cavallaro S. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type 1 astrocytes. Eur J Neurosci 1999; 11:2767-2772. (Pubitemid 29364193)
4. Watanabe J, Nakamachi T, Matsuno R, Hayashi D, Nakamura M, Kikuyama S, et al. Localization, characterization and function of pituitary adenylate cyclise-activating polypeptide during brain development. Peptides 2007; 28:1713-1719. (Pubitemid 47364750)
5. Dejda A, Jozwiak-Bebenista M, Nowak JZ. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures. Ann N Y Acad Sci 2006; 1070:220-225.
6. Jozwiak-Bebenista M, Dejda A, Nowak JZ. Effects of PACAP, VIP and related peptides on cyclic AMP formation in rat neuronal and astrocyte cultures and cerebral cortical slices. Pharmacol Rep 2007; 59:414-420.
7. Dejda A, Sokołowska P, Nowak JZ. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol Rep 2005; 57:307-320. (Pubitemid 41030690)
8. Armstrong BD, Abad C, Chhith S, Cheung-Lau G, Hajji OE, Nobuta H, Waschek JA. Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclise activating peptide. Neuroscience 2008; 151:63-73.
9. Coutaux A, Adam F, Willer J-C, Le Bars D. Hyperalgesia and allodynia: peripheral mechanisms. Joint Bone Spine 2005; 72:359-371.
10. Blomstrand F, Khatibi S, Muyderman H, Hansson E, Olsson T, Rönnbäck L. 5-Hydroxytryptamine and glutamate modulate velocity and extent of intercellular calcium signalling in hippocampal astroglial cells in primary cultures. Neuroscience 1999; 88:1241-1253. (Pubitemid 28547001)
11. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 2003; 26:523-530. (Pubitemid 37176906)
12. Hansson E, Rönnbäck L. Astrocytic receptors and second messenger systems. Adv Molec Cell Biol 2004; 31:475-501. (Pubitemid 137640689)
13. Hansson E, Rönnbäck L, Persson LI, Lowenthal A, Noppe M, Alling C, et al. Cellular composition of primary cultures from cerebral cortex, striatum, hippocampus, brainstem and cerebellum. Brain Res 1984; 300:9-18. (Pubitemid 14104088)
14. Hansson E, Westerlund A, Björklund U, Olsson T. μ-Opioid agonists inhibit the enhanced intracellular Ca2+ responses in inflammatory activated astrocytes co-cultured with brain endothelial cells. Neuroscience 2008; 155:1237-1249.
15. Delbro D, Westerlund A, Björklund U, Hansson E. In inflammatory reactive astrocytes co-cultured with brain endothelial cells nicotine-evoked Ca2+ transients are attenuated due to IL-b release and rearrangement of actin filaments. Neuroscience 2009; 159:770-779.
16. Abbott NJ, Revest PA, Romero IA. Astrocyte-endothelial interaction: physiology and pathology. Neuropathol Appl Neurobiol 1992; 18:424-433.
17. Berridge MJ. Inositol trisphosphate and calcium oscillations. Biochem Soc Symp 2007; 74:1-7.
18. Moroo I, Tatsuno I, Uchida D, Tanaka T, Saito J, Saito Y, Hirai A. Pituitary adenylate cyclise-activating polypeptide (PACAP) stimulates mitogen activated protein kinase (MAPK) in cultured rat astrocytes. Brain Res 1998; 795:191-196. (Pubitemid 28337830)
19. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Rev Neurosci 2006; 7:41-53.
20. Suk K, Park J-H, Lee W-H. Neuropepeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia. Brain Res 2004; 1026:151-156. (Pubitemid 39336426)
21. Delgado J, Leceta D, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J Leukoc Biol 2003; 73:155-164. (Pubitemid 36125686)
22. Brenneman DE. Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclise-activating polypeptide. Peptides 2007; 28:1720-1726.
23. Hansson E, Abbott NJ, Taylor JA, Dolman DEM, Drndarski S, Rönnbäck L. Induction of receptor-mediated astrocytic calcium oscillations by endothelial cells in a blood-brain barrier model. Society for Neuroscience, 34th Annual Meeting: San Diego, CA, USA: 23-27 October 2004 [abstract].
24. Watkins LR, Hutchinson MR, Ledeboer A,Wiesler-Frank J, Milligan ED, Maier SF. Glia as the 'bad guys': implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun 2007; 21:131-146.
25. Guillot TS, Richardsson JR,Wang MZ, Li YJ, Taylor TN, Ciliax BJ, et al. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides 2008; 42:423-434.
26. Aschner M. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 1998; 19:269-281. (Pubitemid 28150978)
27. Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease. Brit J Pharmacol 2007; 150:963-976. (Pubitemid 46628616)